Laura Sararols Selected Research

Laura Sararols Research Topics

3	Blindness (Hysterical Blindness) 04/2022 - 01/2022
3	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 05/2016
2	Hyperemia 05/2016 - 01/2012
2	Endophthalmitis (Ophthalmia) 01/2012 - 06/2007
2	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2003 - 12/2002
1	Cataract (Cataracts) 04/2022
1	Choroidal Neovascularization 02/2022
1	Vitreous Detachment (Posterior Vitreous Detachment) 01/2018
1	Pain (Aches) 05/2016
1	Eye Hemorrhage 05/2016
1	Uveitis 01/2012
1	Hamartoma 12/2004
1	Macular Edema 06/2003
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 06/2003

3	Retinaldehyde (Retinal)IBA 04/2022 - 01/2022
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022 - 05/2016
2	Ranibizumab (Lucentis)FDA Link 02/2022 - 05/2016
2	brolucizumabIBA 01/2021 - 05/2016
1	Antiglaucoma AgentsIBA 04/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2022
1	Bevacizumab (Avastin)FDA Link 02/2022
1	Vascular Endothelial Growth FactorsIBA 01/2021
1	Coloring Agents (Dyes)IBA 01/2018
1	Immunoglobulin FragmentsIBA 05/2016
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 01/2012
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2012
1	Triamcinolone (Aristocort)FDA Link 01/2012
1	Retinal Pigments (Pigments, Visual)IBA 12/2004
1	Insulin-Like PeptidesIBA 03/2003
1	somatostatin-like peptidesIBA 12/2002